Rapid Change in Fentanyl Prevalence in a Community-Based, High-Risk Sample
Open Access
- 1 March 2018
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 75 (3) , 298-300
Abstract
Planning for the implications of nonprescribed fentanyl use relies on multisource forensic1,2 or clinical samples.3,4 Complementing these descriptions, we report a prospective longitudinal study of change in urine fentanyl prevalence in a high-risk, community-based sample.5Keywords
This publication has 6 references indexed in Scilit:
- Underlying Factors in Drug Overdose DeathsJAMA, 2017
- Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’International Journal of Drug Policy, 2017
- Characterizing fentanyl use in methadone-maintained clientsJournal of Substance Abuse Treatment, 2017
- Addressing the Fentanyl Threat to Public HealthNew England Journal of Medicine, 2017
- The Hotel Study—Clinical and Health Service Effectiveness in a Cohort of Homeless or Marginally Housed PersonsThe Canadian Journal of Psychiatry, 2017
- Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, CanadaHarm Reduction Journal, 2015